Latest News

Cancer Research UK award adenovirus process development contract to the CBF

Posted 16/06/2010

Cancer Research UK has awarded the University of Oxford’s Clinical BioManufacturing Facility (CBF) its first commercial process development contract for the production of an adenovirus vector, for use in treating patients with recurrent ovarian cancer and hepatic metastases associated with colorectal cancer.